Key result
A modified thromboelastography assay using a 25% AUC ratio cut-off demonstrated a sensitivity ranging from 53% to 100% for screening patients with von Willebrand disease.
Why the study?
Does a modified thromboelastography assay accurately screen for von Willebrand disease?
Observational (n=328)
Does a modified thromboelastography assay accurately screen for von Willebrand disease?
A modified TEG assay using ristocetin shows potential as a rapid, point-of-care screening test for von Willebrand disease.
No takes yet. Share an insight, caveat, or question.
Variable sensitivity warrants caution against routine vWD screening use; leaves open need for prospective validation before adoption.
Topf et al. (2011) conducted an observational in von Willebrand disease (n=328). Modified thromboelastography (TEG) assay vs. Standard diagnostic tests was evaluated on Sensitivity for detecting von Willebrand disease. A modified thromboelastography assay using a 25% AUC ratio cut-off demonstrated a sensitivity ranging from 53% to 100% for screening patients with von Willebrand disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: